Record NNP B-NP O
date NN I-NP O
: : O O
2096-09-05 CD O B-DATE
Stonybrook NNP B-NP B-HOSPITAL
Team NNP I-NP O
2 CD O O
Admission NNP B-NP O
Note NN I-NP O
PATIENT NNP B-NP O
: : O O
Dalley NNP B-NP I-PATIENT
, , O I-PATIENT
Wade NNP B-NP I-PATIENT
MRN NNP B-NP O
: : O O
5694653 CD O B-MEDICALRECORD
ADMIT NNP B-NP O
DATE NNP I-NP O
: : O O
09/05/96 CD O B-DATE
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
Xavier NNP I-NP B-DOCTOR
CONTACT NN B-NP O
: : O O
Dr. NNP B-NP O
Xavier NNP I-NP B-DOCTOR
CC NNP B-NP O
: : O O
Diarrhea NNP B-NP O
and CC O O
cough NN B-NP O
HPI NNP B-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
61 CD I-NP B-AGE
y NN I-NP O
.o VBG B-VP O
male JJ B-NP O
w/ JJ I-NP O
h JJ I-NP O
.o NN I-NP O
of IN B-PP O
aspiration NN B-NP O
PNA NNP I-NP O
( -LRB- I-NP O
says VBZ B-VP O
he PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
many JJ B-NP O
bouts NNS I-NP O
over IN B-PP O
past JJ B-NP O
2 CD I-NP O
yrs NNS I-NP O
and CC O O
though IN B-SBAR O
due JJ B-NP O
to TO B-PP O
dyskienisa NN B-NP O
and CC O O
all DT B-NP O
studies NNS I-NP O
in IN B-PP O
past JJ B-NP O
negative JJ I-NP O
) -RRB- I-NP O
, , I-NP O
PE NN I-NP O
, , O O
Promyel NNP B-NP O
. . I-NP O
Leukemia NNP I-NP O
in IN B-PP O
remission NN B-NP O
since IN B-PP O
2090 CD B-NP B-DATE
, , O O
TIA NNP B-NP O
( -LRB- I-NP O
on IN B-PP O
coumadin NN B-NP O
7.5mg CD I-NP O
) -RRB- I-NP O
, , I-NP O
dyskinesia NN I-NP O
, , O O
DM2 NNP B-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
non JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
x2 NN I-NP O
days NNS I-NP O
w/ IN B-PP O
diarrhea NN B-NP O
and CC O O
mild JJ B-NP O
nausea NN I-NP O
. . O O
Diarrhea NNP B-NP O
began VBD B-VP O
at IN B-PP O
1:00am CD B-NP O
night NN I-NP O
before IN B-SBAR O
he PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
by IN B-PP O
PCP. NNP B-NP O
Had VBD B-VP O
hamburger NN B-NP O
and CC O O
hot JJ B-NP O
dog NN I-NP O
the DT B-NP O
night NN I-NP O
before IN B-PP O
. . O O
No DT B-NP O
history NN I-NP O
of IN B-PP O
C. NNP B-NP O
Diff NNP I-NP O
in IN B-PP O
past JJ B-NP O
, , O O
was VBD B-VP O
not RB B-ADVP O
on IN B-PP O
abx NN B-NP O
at IN B-PP O
the DT B-NP O
time NN I-NP O
, , O O
and CC O O
only RB B-NP O
sick JJ I-NP O
contact NN I-NP O
was VBD B-VP O
wife NN B-NP O
who WP B-NP O
had VBD B-VP O
bronchitis NN B-NP O
that IN B-INTJ O
began VBD B-VP O
2 CD B-NP O
days NNS I-NP O
prior RB B-ADVP O
but CC O O
she PRP B-NP O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
any DT B-NP O
GI NN I-NP O
symptoms NNS I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
by IN B-PP O
PCP NNP B-NP O
dr NN I-NP O
. . O O
xavier JJR O B-DOCTOR
the DT B-NP O
next JJ I-NP O
day NN I-NP O
who WP B-VP O
though IN B-SBAR O
he PRP B-NP O
had VBD B-VP O
a DT B-NP O
PNA NNP I-NP O
and CC O O
felt VBD B-VP O
GI JJ B-NP O
symptoms NNS I-NP O
were VBD B-VP O
food NN B-NP O
or CC O O
PNA NNP B-NP O
related VBD B-VP O
. . O O
He PRP B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
augmentin NN B-NP O
875/125 IN B-PP O
which WDT B-NP O
did VBD B-VP O
not RB I-VP O
help VB I-VP O
him PRP B-NP O
. . O O
The DT B-NP O
diarrhea NN I-NP O
worsened VBD B-VP O
but CC O O
denied VBD B-VP O
BRPR NN B-NP O
, , I-NP O
melena NN I-NP O
, , O O
Hematoschezia NNP B-NP O
. . I-NP O
Colonsocopy NNP I-NP O
in IN B-PP O
past NN B-NP O
only RB B-ADJP O
significant JJ I-ADJP O
for IN B-PP O
diverticulosis NN B-NP O
. . O O
He PRP B-NP O
took VBD B-VP O
his PRP$ B-NP O
temp NN I-NP O
at IN B-PP O
home NN B-NP O
and CC O O
was VBD B-VP O
102.8 CD B-NP O
and CC O O
had VBD B-VP O
episode NN B-NP O
of IN B-PP O
chills NNS B-NP O
but CC O O
no DT B-NP O
CP CD I-NP O
, , O O
SOB NNP B-NP O
, , O O
Ab CD B-NP O
Pain NNP I-NP O
, , I-NP O
or CC I-NP O
other JJ I-NP O
symptoms NNS I-NP O
. . O O
No DT B-NP O
recent JJ I-NP O
travel NN I-NP O
, , O O
sputum NN B-NP O
was VBD B-VP O
clear JJ B-ADJP O
and CC I-ADJP O
minimal JJ I-ADJP O
, , O O
and CC O O
no DT B-NP O
hemoptysis NN I-NP O
. . O O
No DT B-NP O
recent JJ I-NP O
hospitalizations NNS I-NP O
. . O O
Was VBD B-VP O
advised VBN I-VP O
to TO I-VP O
come VB I-VP O
to TO B-PP O
ED NNP B-NP O
by IN B-PP O
PCP. NNP B-NP O
ED VBN B-NP O
COURSE NN I-NP O
: : O O
In IN B-PP O
the DT B-NP O
ED VBN I-NP O
his PRP$ B-NP O
Vs NNS I-NP O
were VBD B-VP O
98.8 CD B-NP O
, , I-NP O
88-109 CD I-NP O
, , I-NP O
112-145/63-77 CD I-NP O
, , I-NP O
22-24 CD I-NP O
, , I-NP O
93 CD I-NP O
% NN I-NP O
on IN B-PP O
2L JJ B-NP O
and CC I-NP O
94 CD I-NP O
% NN I-NP O
on IN B-PP O
2L. DT B-NP O
He PRP I-NP O
as RB I-NP O
given VBN I-NP O
fluids NNS I-NP O
, , O O
Levofloxacin NNP B-NP O
750mg CD I-NP O
x1 CD I-NP O
, , O O
Mg NNP B-NP O
and CC O O
K NNP B-NP O
was VBD B-VP O
repleted VBN I-VP O
as IN B-SBAR O
it PRP B-NP O
was VBD B-VP O
1.5 CD B-NP O
and CC I-NP O
3.3 CD I-NP O
respectively RB I-NP O
. . O O
CXR '' O O
showed VBD B-VP O
LLL NNP B-NP O
PNA NNP I-NP O
. . I-NP O
Bcx NNP I-NP O
sent VBD B-VP O
. . O O
OTHER NNP B-NP O
ROS NNP I-NP O
: : O O
Negative JJ B-NP O
except IN B-PP O
per IN B-PP O
history NN B-NP O
MEDICAL NNP B-NP O
HISTORY NN I-NP O
Promyelocytic NNP B-NP O
Leukemia NNP I-NP O
in IN B-PP O
remission NN B-NP O
for IN B-PP O
since IN B-NP O
08/2090 CD I-NP B-DATE
Dyskinesia NNP B-NP O
likely JJ I-NP O
2/2 CD I-NP O
to TO B-VP O
perphenazine VB I-VP O
exposure NN B-NP O
during IN B-PP O
last JJ B-NP O
chemo NN I-NP O
HTN NN B-NP O
now RB B-VP O
resolved VBN I-VP O
PE NN B-NP O
in IN B-PP O
3/93 CD B-NP B-DATE
s/p NN I-NP O
thyroid VBD B-VP O
nodule NN B-NP O
removal NN I-NP O
and CC O O
was VBD B-VP O
on IN B-PP O
6mo JJ B-NP O
course NN I-NP O
of IN B-PP O
coumadin NN B-NP O
TIA NNP B-NP O
at IN B-PP O
PCH NNP B-NP B-HOSPITAL
in IN B-PP O
7/93 CD B-NP B-DATE
and CC O O
on IN B-PP O
coumadin NN B-NP O
since IN B-PP O
. . B-NP O
Past NNP I-NP O
coag NN I-NP O
work-up NN I-NP O
negative JJ O O
PNA NNP B-NP O
- : O O
h/o NN B-NP O
of IN B-PP O
aspiration NN B-NP O
pneumonia NN I-NP O
DM2 . O O
s/p NN B-NP O
subtotal JJ I-NP O
thyroidectomy NN I-NP O
( -LRB- O O
no DT B-NP O
cancer NN I-NP O
) -RRB- I-NP O
on IN B-PP O
levo NN B-NP O
for IN B-PP O
hypthroid NN B-NP O
Spondylosis NN B-NP O
DM2 . O O
Colonoscopy NNP B-NP O
in IN B-PP O
2094 CD B-NP B-DATE
showed VBD B-VP O
divertiuclosis NN B-NP O
but CC O O
no DT B-NP O
polyps NNS I-NP O
Echo NNP B-NP O
in IN B-PP O
2093 CD B-NP B-DATE
was VBD B-VP O
nml JJ B-NP O
w/ JJ I-NP O
EF NN I-NP O
of IN B-PP O
60 CD B-NP O
% NN I-NP O
Barium NNP B-NP O
swallow NN I-NP O
in IN B-PP O
2093 CD B-NP B-DATE
normal JJ I-NP O
FAMILY NNP B-NP O
HISTORY NN I-NP O
Mother NNP B-NP O
died VBD B-VP O
of IN B-PP O
breast NN B-NP O
Ca MD B-VP O
at IN B-PP O
76 CD B-NP B-AGE
and CC O O
father NN B-NP O
of IN B-PP O
MI NNP B-NP O
at IN B-PP O
67 CD B-NP B-AGE
2 CD B-NP O
daughters NNS I-NP O
are VBP B-VP O
healthy JJ O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
1ppd JJ B-ADJP O
for IN B-PP O
15yrs NNS B-NP O
and CC O O
stopped VBD B-NP O
15yrs NNS I-NP O
ago IN B-PP O
Rare NNP B-NP O
EtOH NNP I-NP O
Works NNP B-NP O
at IN B-PP O
dupont NN B-NP B-ORGANIZATION
ALLERGIES NNS B-NP O
: : O O
Perphenazine NNP B-NP O
, , O O
caused VBD B-VP O
dyskinesia NN O O
MEDICATIONS NNS B-NP O
ON IN B-PP O
ADMISSION NN B-NP O
1 LS O O
. . B-NP O
Acetylsalicylic NNP I-NP O
Acid NNP I-NP O
( -LRB- I-NP O
Aspirin NN I-NP O
) -RRB- I-NP O
PO NN I-NP O
QD IN B-PP O
81MG JJ B-NP O
form NN I-NP O
: : O O
TABLET NNP B-NP O
CHEWABLE NNP I-NP O
take VBP B-VP O
: : O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
2. . B-NP O
Albuterol NNP I-NP O
Inhaler NNP I-NP O
Hfa NNP I-NP O
( -LRB- I-NP O
Proair NN I-NP O
Hfa NNP I-NP O
) -RRB- I-NP O
2 CD I-NP O
PUFF NN I-NP O
INH IN B-PP O
QID NNP B-NP O
prn NN I-NP O
wheeze/cough IN B-PP O
3. . B-NP O
Tessalon NNP I-NP O
Perles NNP I-NP O
( -LRB- I-NP O
Benzonatate NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
TID NNP I-NP O
prn NN I-NP O
cough NN I-NP O
100MG JJ I-NP O
form NN I-NP O
: : O O
CAPSULE NNP B-NP O
LF NNP I-NP O
take VBP B-VP O
: : O O
1 CD B-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- O O
4 CD B-LST O
. . O O
Clozapine NNP B-NP O
125 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
5 CD B-NP O
. . O O
Levothyroxine NNP B-NP O
Sodium NNP I-NP O
125 CD I-NP O
MCG NNP I-NP O
PO NNP I-NP O
QD . O O
6 CD B-NP O
. . O O
Metformin NNP B-NP O
850 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
with IN B-PP O
meals NNS B-NP O
7. . B-NP O
Multivitamins NNP I-NP O
1 CD I-NP O
CAPSULE NNP I-NP O
PO NNP I-NP O
QD . O O
8. CD B-NP O
Prilosec NNP I-NP O
( -LRB- I-NP O
Omeprazole NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNS I-NP O
20MG JJ I-NP O
form NN I-NP O
: : O O
CAPSULE JJ B-NP O
CR VBD B-VP O
take VB I-VP O
: : O O
1 CD B-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- O O
9 CD B-NP O
. . O O
Reserpine NNP O O
1.5 CD B-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
10 CD B-NP O
. . O O
Simvastatin NNP B-NP O
20 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QHS . O O
11 CD B-NP O
. . O O
Sitagliptin NNP O O
( -LRB- O O
Januvia NNP B-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
12 CD B-NP O
. . O O
Venlafaxine NNP B-NP O
Extended NNP I-NP O
Release NNP I-NP O
( -LRB- I-NP O
Effexor NN I-NP O
Xr NN I-NP O
) -RRB- I-NP O
150 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
13 CD B-NP O
. . O O
Warfarin NNP B-NP O
Sodium NNP I-NP O
7.5 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QPM NNP I-NP O
adjusted VBD B-VP O
to TO I-VP O
maintain VB I-VP O
INR NNP B-NP O
2-3 CD I-NP O
. . O O
PHYSICAL NNP B-NP O
EXAM NNPS I-NP O
VITALS NNS B-NP O
: : O O
99.1 CD B-NP O
, , I-NP O
89 CD I-NP O
, , I-NP O
121/71 CD I-NP O
, , I-NP O
20 CD I-NP O
, , I-NP O
96 CD I-NP O
% NN I-NP O
on IN B-PP O
4L CD B-NP O
Gen NNP B-NP O
: : O O
NAD NNP B-NP O
, , O O
A&amp;Ox3 . O O
HEENT NNP B-NP O
: : O O
oral JJ B-NP O
mucosa NN I-NP O
clear JJ I-NP O
, , O O
no DT B-NP O
lymphadenopathy NN I-NP O
, , O O
PERLA NNP B-NP O
, , O O
EOMI NNP B-NP O
Neck NNP B-NP O
: : O O
no DT B-NP O
JVP NNP I-NP O
, , O O
no DT B-NP O
nodules NNS I-NP O
, , O O
no DT B-NP O
tenderness NN I-NP O
Chest NNP B-NP O
: : O O
Rhonci NNP B-NP O
most JJS I-NP O
pronounced VBD B-VP O
on IN B-PP O
left JJ B-NP O
and CC I-NP O
e-a JJ I-NP O
changes NNS I-NP O
on IN B-PP O
LL NNP B-NP O
base NN I-NP O
CVS NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
no DT B-NP O
MRG NN I-NP O
Ab CD B-NP O
: : O O
soft JJ B-ADJP O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
No DT B-NP O
rebound NN I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
Labs NNS B-NP O
CBC NNP B-NP O
: : O O
8.6/38.5/198 CD B-NP O
Electrolytes NNP I-NP O
: : O O
Na NNP B-NP O
137 CD I-NP O
, , O O
K NNP B-NP O
3.3 CD I-NP O
, , O O
Cl NNP B-NP O
103 CD I-NP O
, , O O
CO2 NNP B-NP O
24,5 CD I-NP O
, , O O
BUN/Cr NNP B-NP O
12/1.30 CD I-NP O
Ca MD B-PP O
9.4 CD B-NP O
, , O O
Mg NNP B-NP O
1.3 CD I-NP O
, , O O
Phos NNP B-NP O
2.5 CD I-NP O
INR NNP B-NP O
3.5 CD I-NP O
, , O O
UA NNP B-NP O
-, , O O
Bcx NNP B-NP O
in IN B-PP O
past JJ B-NP O
negative JJ I-NP O
Radiology NN B-NP O
CXR NN B-NP O
: : O O
LLL NNP B-NP O
PNA NNP I-NP O
ASSESSMENT NNP B-NP O
&amp; NNP I-NP O
PLAN NNP I-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
61 CD I-NP B-AGE
y NN I-NP O
.o VBG B-VP O
male JJ B-NP O
w/ JJ I-NP O
h JJ I-NP O
.o NN I-NP O
of IN B-PP O
aspiration NN B-NP O
PNA NNP I-NP O
, , O O
PE NN B-NP O
, , O O
Promyel NNP B-NP O
. . I-NP O
Leukemia NNP I-NP O
in IN B-PP O
remission NN B-NP O
since IN B-PP O
2090 CD B-NP B-DATE
, , O O
TIA NNP B-NP O
( -LRB- I-NP O
on IN B-PP O
coumadin NN B-NP O
7.5mg CD I-NP O
) -RRB- I-NP O
, , I-NP O
dyskinesia NN I-NP O
, , O O
DM2 NNP B-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
non JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
x2 NN I-NP O
days NNS I-NP O
w/ IN B-PP O
diarrhea NN B-NP O
and CC O O
mild JJ B-NP O
nausea NN I-NP O
. . O O
The DT B-NP O
diarrhea NN I-NP O
seems VBZ B-VP O
to TO I-VP O
have VB I-VP O
been VBN I-VP O
present JJ B-ADJP O
before IN B-PP O
the DT B-NP O
abx NN I-NP O
and CC O O
like IN B-SBAR O
worsened VBN B-VP O
by IN B-PP O
it PRP B-NP O
. . O O
Considering VBG B-VP O
its PRP$ B-NP O
sudden JJ I-NP O
nature NN I-NP O
after IN B-PP O
meal NN B-NP O
likely RB I-NP O
a DT B-NP O
gastroenteritis NN I-NP O
and CC O O
it PRP B-NP O
is VBZ B-VP O
now RB I-VP O
worsened VBN I-VP O
with IN B-PP O
augmenting VBG B-NP O
. . O O
His PRP$ B-NP O
PNA NNP I-NP O
is VBZ B-VP O
either DT B-NP O
2/2 CD I-NP O
to TO B-PP O
aspiration NN B-NP O
or CC I-NP O
CAP. NNP I-NP O
ISSUE NNP B-NP O
# # I-NP O
1 CD I-NP O
: : O O
PNA NNP B-NP O
- : O O
will MD B-VP O
tx VB I-VP O
with IN B-PP O
levo NN B-NP O
750mg CD I-NP O
po NN I-NP O
x5-7 CD B-NP O
days NNS I-NP O
. . O O
Remains NNS B-NP O
afebrile JJ B-ADJP O
and CC O O
BP NNP B-NP O
stable NN I-NP O
- : O O
BCX NNP B-NP O
, , O O
UCx NNP B-NP O
, , O O
Urine NNP B-NP O
Legionella NNP I-NP O
ISSUE NNP B-NP O
# # I-NP O
2 CD I-NP O
: : O O
Combination NN B-NP O
of IN B-PP O
gastroenteritis NN B-NP O
and CC O O
worsened VBN B-VP O
by IN B-PP O
augmentin NN B-NP O
- : O O
Stop VB B-VP O
augmentin NN B-NP O
- : B-NP O
Send NNP I-NP O
C. NNP I-NP O
Diff NNP I-NP O
and CC O O
dydrate NN B-NP O
ISSUE NNP B-NP O
# # I-NP O
3 CD I-NP O
: : O O
Cr NNP B-NP O
increase VB B-VP O
- : O O
likely JJ B-NP O
pre-renal JJ I-NP O
and CC O O
will MD B-VP O
give VB I-VP O
fluids NNS B-NP O
. . O O
If IN O O
does VBZ B-VP O
not RB I-VP O
resolve VB I-VP O
will MD B-VP O
send VB I-VP O
urine NN B-NP O
studies NNS I-NP O
ISSUE NNP B-NP O
# # I-NP O
4 CD I-NP O
: : O O
DM2- NNP B-NP O
will MD B-VP O
hold VB I-VP O
metformin NN B-NP O
and CC I-NP O
juanivia NN I-NP O
and CC O O
start VB B-VP O
sliding VBG B-NP O
scale NN I-NP O
while IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
in IN B-PP O
the DT B-NP O
hospital NN I-NP O
ISSUE NNP B-NP O
# # I-NP O
5 CD I-NP O
: : O O
h/o NN B-NP O
of IN B-PP O
TIA NNP B-NP O
and CC O O
supratherapeutic JJ B-NP O
INR- NNS I-NP O
will MD B-VP O
hold VB I-VP O
coumadin NN B-NP O
today NN I-NP O
and CC O O
recheck VB B-VP O
INR NNP B-NP O
tommarow NN I-NP O
and CC O O
adjust VBP B-VP O
accordingly RB O O
Otherwise RB B-ADVP O
for IN B-PP O
all DT B-NP O
other JJ I-NP O
PMHx NNP I-NP O
issues NNS I-NP O
will MD B-VP O
maintain VB I-VP O
on IN B-PP O
home NN B-NP O
medications NNS I-NP O
as IN B-SBAR O
they PRP B-NP O
are VBP B-VP O
not RB O O
active JJ B-NP O
issues NNS I-NP O
at IN B-PP O
this DT B-NP O
point NN I-NP O
FEN NNS B-NP O
: : O O
Regular NNP B-NP O
diabetic NN I-NP O
diet NN I-NP O
. . O O
Fluids NNS B-NP O
of IN B-PP O
NS NNS B-NP O
at IN B-PP O
125cc/hr CD B-NP O
PROPHYLAXIS NNS B-NP O
GI NNP B-NP O
: : O O
Colace NNP B-NP O
, , O O
senna VBD B-VP O
. . B-NP O
Continue NNP I-NP O
PPI NNP I-NP O
DVT NNP B-NP O
: : O O
Already RB B-ADVP O
on IN B-PP O
coumadin NN B-NP O
CODE NNP B-NP O
: : O O
Full NNP O O
Jonnie NNP B-NP B-DOCTOR
Vue NNP I-NP I-DOCTOR
, , O O
Pager NNP B-NP O
36407 CD I-NP B-PHONE
